Trial NCT03712787

View at ClinicalTrials.gov 
Org. Study IDs: M15-570
Secondary IDs: 2018-000268-26

Last trial update was posted on 2022-09-22

MeSH Interventions

Tilavonemab

MeSH Conditions

Alzheimer Disease

Other Conditions

Alzheimer's Disease

Stopping Reasons

Discontinued because of lack of efficacy in the parent study (Study M15-566; NCT02880956).

Limitations And Caveats

Study M15-570 was discontinued because of lack of efficacy in the parent study (Study M15-566) and 2) the tilavonemab development program was discontinued.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID